Re: LabCorp to purchase Bio by year end
Never going to happen. LabCorp looked at BIO a few years ago. They walked away. The reason is that BIO had so much bad debt, Grey Area billing etc, LabCorp felth there was to much liability.
Genpath is a bundle of Medicare Fraud and LabCorp knows this.